Stephanie Berg
DO
Instructor of Medicine, Senior Physician
Dana-Farber Cancer Institute , Lank Center for Genitourinary Oncology, Harvard Medical School

Dr. Berg is a genitourinary medical oncologist and Excuetive Officer in the Alliance for Clinical Trials for Oncology in the Genitourinary Committee and Experimental Therapeutics/Rare Tumors Committee. Dr. Berg initially joined Loyola University Chicago in 2018 as junior faculty lead of the Genitourinary Oncology Program with a focus on translational science and clinical trial development for patients with rare urologic cancers. She is currently at the Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology and instructor of medicine at Harvard Medical School. She is also a senior physician at Dana-Farber Cancer Institute. Her main role at Alliance is design of clinical trials sponsored by Alliance through the National Cancer Instutite National Cinical Trials Network.

Sessions

Register
General Session

First-Line Strategies in Metastatic Renal Cancer: Doublet Immune Checkpoint Blockade vs Immune Checkpoint Blockade Plus VEGFR TKI

Saturday, March 14, 2026
2:10 PM - 2:55 PM
General Session

Immune Checkpoint Blockade Plus VEGFR TKI

Saturday, March 14, 2026
2:30 PM - 2:50 PM
General Session

First-Line Strategies in Metastatic Renal Cancer: Doublet Immune Checkpoint Blockade vs Immune Checkpoint Blockade Plus VEGFR TKI

Saturday, September 26, 2026
3:30 PM - 4:15 PM
General Session

Immune Checkpoint Blockade Plus VEGFR TKI

Saturday, September 26, 2026
3:50 PM - 4:10 PM
Back to top